CLINICAL_TRIALS trial_result · 2023-06-26

Clinical Trial Update: A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression [Phase 2]

A Phase 2 study evaluating the efficacy of JNJ-67953964 for major depressive disorder has completed, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2023-06-26